These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 16105242)

  • 1. Long-term treatment with Hachimi-jio-gan attenuates kidney damage in spontaneously diabetic WBN/Kob rats.
    Nakagawa T; Yokozawa T; Yamabe N; Rhyn DY; Goto H; Shimada Y; Shibahara N
    J Pharm Pharmacol; 2005 Sep; 57(9):1205-12. PubMed ID: 16105242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of the Chinese prescription Hachimi-jio-gan against renal damage in the Otsuka Long-Evans Tokushima fatty rat: a model of human type 2 diabetes mellitus.
    Yamabe N; Yokozawa T
    J Pharm Pharmacol; 2006 Apr; 58(4):535-45. PubMed ID: 16597372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effects of keishibukuryogan on the kidney of spontaneously diabetic WBN/Kob rats.
    Nakagawa T; Goto H; Hikiami H; Yokozawa T; Shibahara N; Shimada Y
    J Ethnopharmacol; 2007 Mar; 110(2):311-7. PubMed ID: 17123761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of Hachimi-jio-gan against the development of pancreatic fibrosis and oxidative damage in Otsuka Long-Evans Tokushima Fatty rats.
    Yamabe N; Yokozawa T
    J Ethnopharmacol; 2007 Aug; 113(1):91-9. PubMed ID: 17606344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effect of Hachimi-jio-gan against renal failure in a subtotal nephrectomy rat model.
    Yamabe N; Yokozawa T; Kim HY; Cho EJ
    J Pharm Pharmacol; 2005 Dec; 57(12):1637-44. PubMed ID: 16354408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study on the effects to diabetic nephropathy of Hachimi-jio-gan in rats.
    Yokozawa T; Yamabe N; Cho EJ; Nakagawa T; Oowada S
    Nephron Exp Nephrol; 2004; 97(2):e38-48. PubMed ID: 15218322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effects of the Chinese prescription Hachimi-jio-gan against diabetic oxidative stress.
    Kim HY; Yokozawa T; Cho EJ; Yamabe N
    J Pharm Pharmacol; 2004 Oct; 56(10):1299-305. PubMed ID: 15482645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The amelioration of streptozotocin diabetes-induced renal damage by Wu-Ling-San (Hoelen Five Herb Formula), a traditional Chinese prescription.
    Liu IM; Tzeng TF; Liou SS; Chang CJ
    J Ethnopharmacol; 2009 Jul; 124(2):211-8. PubMed ID: 19397971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rokumi-jio-gan-containing prescriptions regulate oxidative stress through improving dyslipidemia in a subtotal nephrectomized rat model.
    Park CH; Lee SL; Noh JS; Yokozawa T
    J Ethnopharmacol; 2013 Jul; 148(2):449-58. PubMed ID: 23639360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beneficial effect of Corni Fructus, a constituent of Hachimi-jio-gan, on advanced glycation end-product-mediated renal injury in Streptozotocin-treated diabetic rats.
    Yamabe N; Kang KS; Goto E; Tanaka T; Yokozawa T
    Biol Pharm Bull; 2007 Mar; 30(3):520-6. PubMed ID: 17329849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression patterns of plasma proteins in spontaneously diabetic rats after oral administration of a Kampo medicine, Hachimi-jio-gan, using SELDI ProteinChip platform.
    Kiga C; Nakagawa T; Koizumi K; Sakurai H; Shibagaki Y; Ogawa K; Goto H; Saiki I
    Biol Pharm Bull; 2005 Jun; 28(6):1031-7. PubMed ID: 15930740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effects of morroniside isolated from Corni Fructus against renal damage in streptozotocin-induced diabetic rats.
    Yokozawa T; Yamabe N; Kim HY; Kang KS; Hur JM; Park CH; Tanaka T
    Biol Pharm Bull; 2008 Jul; 31(7):1422-8. PubMed ID: 18591786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effect of Gymnema montanum against renal damage in experimental diabetic rats.
    Ramkumar KM; Ponmanickam P; Velayuthaprabhu S; Archunan G; Rajaguru P
    Food Chem Toxicol; 2009 Oct; 47(10):2516-21. PubMed ID: 19616598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic usefulness of Keishi-bukuryo-gan for diabetic nephropathy.
    Nakagawa T; Yokozawa T; Terasawa K; Nakanishi K
    J Pharm Pharmacol; 2003 Feb; 55(2):219-27. PubMed ID: 12631415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of transforming growth factor-beta1 gene expression by Danggui buxue tang, a traditional Chinese herbal preparation, in retarding the progress of renal damage in streptozotocin-induced diabetic rats.
    Zhang YW; Xie D; Xia B; Zhen RT; Liu IM; Cheng JT
    Horm Metab Res; 2006 Feb; 38(2):82-8. PubMed ID: 16523407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protease administration decreases enhanced transforming growth factor-beta 1 content in isolated glomeruli of diabetic rats.
    Paczek L; Gaciong Z; Bartlomiejczyk I; Sebekova K; Birkenmeier G; Heidland A
    Drugs Exp Clin Res; 2001; 27(4):141-9. PubMed ID: 11822224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effect of Gui Qi mixture on the progression of diabetic nephropathy in rats.
    Zhang YW; Xie D; Chen YX; Zhang HY; Xia ZX
    Exp Clin Endocrinol Diabetes; 2006 Nov; 114(10):563-8. PubMed ID: 17177138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of KIOM-79 on hyperglycemia and diabetic nephropathy in type 2 diabetic Goto-Kakizaki rats.
    Kim CS; Sohn EJ; Kim YS; Jung DH; Jang DS; Lee YM; Kim DH; Kim JS
    J Ethnopharmacol; 2007 May; 111(2):240-7. PubMed ID: 17194556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Keishi-bukuryo-gan on vascular function and hemorheological factors in spontaneously diabetic (WBN/kob) rats.
    Goto H; Shimada Y; Sekiya N; Yang Q; Kogure T; Mantani N; Hikiami H; Shibahara N; Terasawa K
    Phytomedicine; 2004 Feb; 11(2-3):188-95. PubMed ID: 15070171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zhenqing recipe alleviates diabetic nephropathy in experimental type 2 diabetic rats through suppression of SREBP-1c.
    Wen X; Zeng Y; Liu L; Zhang H; Xu W; Li N; Jia X
    J Ethnopharmacol; 2012 Jun; 142(1):144-50. PubMed ID: 22564814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.